Spot the MoneyInsiders
Data Live

Insider / JOHNSON & JOHNSON

Schmid Timothy

EVP, WW Chair, MedTech at JOHNSON & JOHNSON · JNJ

Schmid Timothy, EVP, WW Chair, MedTech at JOHNSON & JOHNSON, has disclosed 6 transactions in JNJ since September 4, 2026: 0 purchases (0 open-market buys) and 2 sales, worth about $14.1M at the reported prices. The latest was filed September 4, 2026, 2 days after the trade.

Last updated September 4, 2026 · Source: SEC EDGAR Form 4 filings

Transactions
6
Open-market buys
0
Sales
2
Avg. disclosure lag
2.0d

Transactions

SecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSource
JNJOption / conversion MSeptember 2, 2026September 4, 20262d22,527——derivativeForm 4 ↗
JNJOption / conversion MSeptember 2, 2026September 4, 20262d11,070——derivativeForm 4 ↗
JNJSell SSeptember 2, 2026September 4, 20262d22,527$275$6.2MForm 4 ↗
JNJOption / conversion MSeptember 2, 2026September 4, 20262d22,527$151$3.4MForm 4 ↗
JNJSell SSeptember 2, 2026September 4, 20262d11,070$275$3.0MForm 4 ↗
JNJOption / conversion MSeptember 2, 2026September 4, 20262d11,070$132$1.5MForm 4 ↗

Filings

FiledFormAccessionRowsStatusSource
September 4, 2026Form 40000200406-26-0001796publishedEDGAR ↗

Sources and method

Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.

Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.